WSM 2015 Slides

While traditional competitors in Medicine are focusing on Clinical Decision Support to compete with UTD; non-traditional players are a potential threat

Niche Startups

• Larger portfolio, though P&E’s ME list has greater depth and curriculum coverage. • Elsevier focus is almost exclusively on institutional sales via Clinical Key • Sunsetting both MD Consult and Expert Consult and have replatformed Expert Consult on Inkling to support sales to individuals. • Aggressively transforming business from individual to institutional: new technology platform (Clinical Key), marketing and sales (eliminated PSG reps and used heads for CK), editorial (acquisition editors now content specialists focused on filling CK gaps).

• P&E content generally broader and deeper in both Med Practice and Med Ed. P&E lacks a core reference in Internal Medicine to compete with Harrison’s; M-H also has stronger position in USMLE and other Med Ed review. • Mature institutional offerings with Access series; Access products recently replatformed. • Moving into CDS with launch of Clinical Access.

• A number of focused niche players have emerged to serve the unmet needs of specific specialty areas (e.g., Pathoma in Medical Education course review; Orthobullets in Orthopedic Surgery residency education).

MEDICINE

Implications for WK

Implications for WK

Implications for WK

• Elsevier’s pivot toward Clinical Decision Support leaves open space in medical learning, but P&E needs strong institutional capabilities quickly to succeed (platform, product, marketing and sales).

• M-H is limited by the size and narrower focus of Medical portfolio. M-H, however does publish in areas where WK is strong ; thus, they are ahead of us with institutional specialty offerings in Anesthesiology, Surgery. WK needs similar specialty-specific offerings or risks losing dominant market position. Collections in Health Library should counter the threat.

• While these players are small, they have the potential to disintermediate WK in key specialty areas. WK should accelerate offerings in specialties where niche players are gaining ground and/or look at acquiring them.

7